These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 26021827)

  • 21. A truncated C-terminal fragment of Mycobacterium tuberculosis HSP70 gene enhanced potency of HBV DNA vaccine.
    Li X; Yang X; Li L; Liu H; Liu J
    Vaccine; 2006 Apr; 24(16):3321-31. PubMed ID: 16472546
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Induction of neutralizing antibodies and Th1-polarized and CD4-independent CD8+ T-cell responses following delivery of human immunodeficiency virus type 1 Tat protein by recombinant adenylate cyclase of Bordetella pertussis.
    Mascarell L; Fayolle C; Bauche C; Ladant D; Leclerc C
    J Virol; 2005 Aug; 79(15):9872-84. PubMed ID: 16014948
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increased immunogenicity of HIV-1 p24 and gp120 following immunization with gp120/p24 fusion protein vaccine expressing alpha-gal epitopes.
    Abdel-Motal UM; Wang S; Awad A; Lu S; Wigglesworth K; Galili U
    Vaccine; 2010 Feb; 28(7):1758-65. PubMed ID: 20034607
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Liposome-encapsulated HIV-1 Gag p24 containing lipid A induces effector CD4+ T-cells, memory CD8+ T-cells, and pro-inflammatory cytokines.
    Steers NJ; Peachman KK; McClain S; Alving CR; Rao M
    Vaccine; 2009 Nov; 27(49):6939-49. PubMed ID: 19748578
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunization with HIV Gag targeted to dendritic cells followed by recombinant New York vaccinia virus induces robust T-cell immunity in nonhuman primates.
    Flynn BJ; Kastenmüller K; Wille-Reece U; Tomaras GD; Alam M; Lindsay RW; Salazar AM; Perdiguero B; Gomez CE; Wagner R; Esteban M; Park CG; Trumpfheller C; Keler T; Pantaleo G; Steinman RM; Seder R
    Proc Natl Acad Sci U S A; 2011 Apr; 108(17):7131-6. PubMed ID: 21467219
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Enhanced generation of cytotoxic T lymphocytes by heat shock protein 70 fusion proteins harboring both CD8(+) T cell and CD4(+) T cell epitopes.
    Takemoto S; Nishikawa M; Guan X; Ohno Y; Yata T; Takakura Y
    Mol Pharm; 2010 Oct; 7(5):1715-23. PubMed ID: 20695521
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vaccine molecules targeting Xcr1 on cross-presenting DCs induce protective CD8+ T-cell responses against influenza virus.
    Fossum E; Grødeland G; Terhorst D; Tveita AA; Vikse E; Mjaaland S; Henri S; Malissen B; Bogen B
    Eur J Immunol; 2015 Feb; 45(2):624-35. PubMed ID: 25410055
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Glycoprotein 96-mediated presentation of human immunodeficiency virus type 1 (HIV-1)-specific human leukocyte antigen class I-restricted peptide and humoral immune responses to HIV-1 p24.
    Gong X; Gai W; Xu J; Zhou W; Tien P
    Clin Vaccine Immunol; 2009 Nov; 16(11):1595-600. PubMed ID: 19776200
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of transduced dendritic cells expressing HIV-1 p24-Nef antigens in HIV-specific cytotoxic T cells induction as a therapeutic candidate vaccine.
    Sadat Larijani M; Ramezani A; Mashhadi Abolghasem Shirazi M; Bolhassani A; Pouriayevali MH; Shahbazi S; Sadat SM
    Virus Res; 2021 Jun; 298():198403. PubMed ID: 33775753
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HIV-1 Gag p24-Nef fusion peptide induces cellular and humoral immune response in a mouse model.
    Mahdavi M; Ebtekar M; Azadmanesh K; Khorramkhorshid HR; Rahbarizadeh F; Yazdi MH; Zabihollahi R; Abolhassani M; Hassan ZM
    Acta Virol; 2010; 54(2):131-6. PubMed ID: 20545443
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Poly(gamma-glutamic acid) nanoparticles as an efficient antigen delivery and adjuvant system: potential for an AIDS vaccine.
    Wang X; Uto T; Akagi T; Akashi M; Baba M
    J Med Virol; 2008 Jan; 80(1):11-9. PubMed ID: 18041033
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Immunological efficiency induced by HIV-1 p24 DNA combined with P24 protein].
    Wang Q; Chen Y; Gao S; Jiang W; Song L; Huang W
    Sheng Wu Gong Cheng Xue Bao; 2011 May; 27(5):773-80. PubMed ID: 21845844
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A multigene HIV type 1 subtype C modified vaccinia Ankara (MVA) vaccine efficiently boosts immune responses to a DNA vaccine in mice.
    Shephard E; Burgers WA; Van Harmelen JH; Monroe JE; Greenhalgh T; Williamson C; Williamson AL
    AIDS Res Hum Retroviruses; 2008 Feb; 24(2):207-17. PubMed ID: 18240963
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neutralizing activity and cellular immune responses induced in mice after immunization with apoptotic HIV-1/murine leukemia virus infected cells.
    Hinkula J; Walther-Jallow L; Laurén A; Mäkitalo B; Oberg M; Wahren B; Fenyö EM; Spetz AL
    Vaccine; 2009 Oct; 27(46):6424-31. PubMed ID: 19549607
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recombinant influenza virus expressing HIV-1 p24 capsid protein induces mucosal HIV-specific CD8 T-cell responses.
    Tan HX; Gilbertson BP; Jegaskanda S; Alcantara S; Amarasena T; Stambas J; McAuley JL; Kent SJ; De Rose R
    Vaccine; 2016 Feb; 34(9):1172-9. PubMed ID: 26826545
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Delivering HIV Gagp24 to DCIR Induces Strong Antibody Responses In Vivo.
    Flamar AL; Contreras V; Zurawski S; Montes M; Dereuddre-Bosquet N; Martinon F; Banchereau J; Le Grand R; Zurawski G; Levy Y
    PLoS One; 2015; 10(9):e0135513. PubMed ID: 26407317
    [TBL] [Abstract][Full Text] [Related]  

  • 37. mRNA-based dendritic cell vaccination induces potent antiviral T-cell responses in HIV-1-infected patients.
    Van Gulck E; Vlieghe E; Vekemans M; Van Tendeloo VF; Van De Velde A; Smits E; Anguille S; Cools N; Goossens H; Mertens L; De Haes W; Wong J; Florence E; Vanham G; Berneman ZN
    AIDS; 2012 Feb; 26(4):F1-12. PubMed ID: 22156965
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunization with HIV-1 Gag protein conjugated to a TLR7/8 agonist results in the generation of HIV-1 Gag-specific Th1 and CD8+ T cell responses.
    Wille-Reece U; Wu CY; Flynn BJ; Kedl RM; Seder RA
    J Immunol; 2005 Jun; 174(12):7676-83. PubMed ID: 15944268
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Improved cellular and humoral immune responses in vivo following targeting of HIV Gag to dendritic cells within human anti-human DEC205 monoclonal antibody.
    Cheong C; Choi JH; Vitale L; He LZ; Trumpfheller C; Bozzacco L; Do Y; Nchinda G; Park SH; Dandamudi DB; Shrestha E; Pack M; Lee HW; Keler T; Steinman RM; Park CG
    Blood; 2010 Nov; 116(19):3828-38. PubMed ID: 20668230
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunogenicity of chloroplast-derived HIV-1 p24 and a p24-Nef fusion protein following subcutaneous and oral administration in mice.
    Gonzalez-Rabade N; McGowan EG; Zhou F; McCabe MS; Bock R; Dix PJ; Gray JC; Ma JK
    Plant Biotechnol J; 2011 Aug; 9(6):629-38. PubMed ID: 21443546
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.